BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

821 related articles for article (PubMed ID: 23541042)

  • 1. Ocular graft-versus-host disease: a review.
    Shikari H; Antin JH; Dana R
    Surv Ophthalmol; 2013; 58(3):233-51. PubMed ID: 23541042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pemphigoid-like ocular lesions in patients with graft-versus-host disease following allogeneic bone marrow transplantation.
    Karwacka E; Ołdakowska-Jedynak U; Brydak-Godowska J; Paczek L; Kecik D
    Transplant Proc; 2006; 38(1):292-4. PubMed ID: 16504728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular findings after allogeneic hematopoietic stem cell transplantation.
    Tabbara KF; Al-Ghamdi A; Al-Mohareb F; Ayas M; Chaudhri N; Al-Sharif F; Al-Zahrani H; Mohammed SY; Nassar A; Aljurf M
    Ophthalmology; 2009 Sep; 116(9):1624-9. PubMed ID: 19729097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular graft-versus-host disease.
    Hessen M; Akpek EK
    Curr Opin Allergy Clin Immunol; 2012 Oct; 12(5):540-7. PubMed ID: 22892710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Kamble RT; Selby GB; Mims M; Kharfan-Dabaja MA; Ozer H; George JN
    Biol Blood Marrow Transplant; 2006 May; 12(5):506-10. PubMed ID: 16635785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular manifestations of graft versus host disease following bone marrow transplantation.
    Claes K; Kestelyn P
    Bull Soc Belge Ophtalmol; 2000; (277):21-6. PubMed ID: 11126670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHD.
    Dietrich-Ntoukas T; Cursiefen C; Westekemper H; Eberwein P; Reinhard T; Bertz H; Nepp J; Lawitschka A; Heiligenhaus A; Seitz B; Messmer EM; Meyer-ter-Vehn T; Basara N; Greinix H; Datiles MB; Lee SJ; Pavletic SZ; Wolff D
    Cornea; 2012 Mar; 31(3):299-310. PubMed ID: 22157574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular graft-versus-host disease after allogeneic stem cell transplantation.
    Westeneng AC; Hettinga Y; Lokhorst H; Verdonck L; van Dorp S; Rothova A
    Cornea; 2010 Jul; 29(7):758-63. PubMed ID: 20489577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic prophylaxis of acute graft-versus-host disease after allogeneic marrow transplantation.
    Schwinghammer TL; Bloom EJ
    Clin Pharm; 1993 Oct; 12(10):736-61. PubMed ID: 8258255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on ocular graft versus host disease.
    Kim SK
    Curr Opin Ophthalmol; 2006 Aug; 17(4):344-8. PubMed ID: 16900025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow transplantation: new approaches to immunosuppression and management of acute graft-versus-host disease.
    Auletta JJ; Cooke KR
    Curr Opin Pediatr; 2009 Feb; 21(1):30-8. PubMed ID: 19242239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current insights into ocular graft-versus-host disease.
    Riemens A; te Boome L; Imhof S; Kuball J; Rothova A
    Curr Opin Ophthalmol; 2010 Nov; 21(6):485-94. PubMed ID: 20729735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic graft-versus-host disease: clinical manifestation and therapy.
    Ratanatharathorn V; Ayash L; Lazarus HM; Fu J; Uberti JP
    Bone Marrow Transplant; 2001 Jul; 28(2):121-9. PubMed ID: 11509929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous graft-versus-host disease: a guide for the dermatologist.
    Häusermann P; Walter RB; Halter J; Biedermann BC; Tichelli A; Itin P; Gratwohl A
    Dermatology; 2008; 216(4):287-304. PubMed ID: 18230976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of topical cyclosporin A in ocular graft-versus-host-disease.
    Kiang E; Tesavibul N; Yee R; Kellaway J; Przepiorka D
    Bone Marrow Transplant; 1998 Jul; 22(2):147-51. PubMed ID: 9707022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow, Transplantation (EBMT). Chronic Leukaemia Working Party of the EBMT.
    Ruutu T; Niederwieser D; Gratwohl A; Apperley JF
    Bone Marrow Transplant; 1997 Apr; 19(8):759-64. PubMed ID: 9134165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colonic graft-versus-host disease.
    Ross WA; Couriel D
    Curr Opin Gastroenterol; 2005 Jan; 21(1):64-9. PubMed ID: 15687887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac manifestations of graft-versus-host disease.
    Rackley C; Schultz KR; Goldman FD; Chan KW; Serrano A; Hulse JE; Gilman AL
    Biol Blood Marrow Transplant; 2005 Oct; 11(10):773-80. PubMed ID: 16182178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant.
    Vogelsang GB; Lee L; Bensen-Kennedy DM
    Annu Rev Med; 2003; 54():29-52. PubMed ID: 12359826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Scoring Criteria for the Evaluation of Ocular Graft-versus-Host Disease in a Preclinical Allogeneic Hematopoietic Stem Cell Transplantation Animal Model.
    Perez VL; Barsam A; Duffort S; Urbieta M; Barreras H; Lightbourn C; Komanduri KV; Levy RB
    Biol Blood Marrow Transplant; 2016 Oct; 22(10):1765-1772. PubMed ID: 27492793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.